Review Volume 14, Issue 18 pp 7635—7649
A comprehensive review of pancreatic cancer and its therapeutic challenges
Figure 1. Pro-pancreatic tumorigenic, aberrant genes/proteins and pathways. Signals mediated by mu-K-ras, mu-p53 and loss of p16INK promote various uncontrollable cell growth, cell cycle progression and etc.